Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Apixaban 0.25-mg/mL Suspension for Enteral Feeding Tube

Author(s):  Allen Loyd V Jr

Issue:  Jul/Aug 2021 - Volume 25, Number 4
View All Articles in Issue

Page(s):  320

Apixaban 0.25-mg/mL Suspension for Enteral Feeding Tube Page 1

Download in electronic PDF format for $65

Abstract:  A formulation for preparing Apixaban 0.25-mg/mL Suspension for Enteral Feeding Tube. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen Jr., PhD, RPh, formulation, apixaban, oral suspension, enteral feeding tubes, selective factor Xa inhibitor, postoperative thromboprophylaxis, blood clots, deep vein thrombosis, pulmonary embolism

Related Categories: FORMULATIONS, CARDIOLOGY, DOSAGE FORMS/DRUG CARRIERS, HEMOSTASIS, BLEEDING, ANTICOAGULATION, SURGERY

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Apixaban 0.25-mg/mL Suspension for Enteral Feeding Tube
Allen Loyd V Jr
Jul/Aug 2021
Pg. 320

Basics of Compounding: Vehicle for Drug Administration via Enteral Feeding Tubes
Allen Loyd V Jr
May/Jun 2022
Pg. 214-217

Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
Nov/Dec 2003
Pg. 449-450

Compounding Rifampin Suspensions with Improved Injectability for Nasogastric Enteral Feeding Tube Administration
de Villiers Melgardt M
, Vogel Laura, Bogenschutz Monica C, Fingerhut Bonnie J, D'Silva Joseph B, Moore Anne
May/Jun 2010
Pg. 250-256

Recommendations for Compounding Medications for Feeding Tube Administration
Klang Mark
Jul/Aug 2010
Pg. 276-282

Compounding with Biotechnology Products, Part 2: Product-specific Considerations
Allen Loyd V Jr
Nov/Dec 2022
Pg. 446-466

The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women
Stephenson Kenna
, Neuenschwander Pierre F, Kurdowska Anna K
Jan/Feb 2013
Pg. 74-85

View Sample
Imatinib 40-mg/mL Oral Suspension
Allen Loyd V Jr
Nov/Dec 2016
Pg. 510

Atomoxetine 4-mg/mL Oral Solution/Suspension
Allen Loyd V Jr
Jul/Aug 2021
Pg. 321

Stability of Clopidogrel in Three Extemporaneously Compounded Oral Liquid Preparations
Yamreudeewong Weeranuj
, Dolence Eric Kurt, Teixeira M Glaucia
Sep/Oct 2011
Pg. 435-437

Particle Measuring Systems - USP <797> Environmental Monitoring Solutions